Advocating for patient access to optimal dermatological care.
Washington, DC
Joined February 2017
- Tweets1.5K
- Following141
- Followers260
- Likes149
November is #NationalHealthySkinMonth!
More than 30 million Americans live with eczema. Treatment options are expanding, but insurance barriers like step therapy and prior authorization can delay care.
Learn more in DCAN’s resource: bit.ly/4BJgRxa
1
2
November is #HyperhidrosisAwarenessMonth!
#DYK? Most people living with #hyperhidrosis have to spend 15 minutes to 1 hour every day just dealing with their symptoms.
Learn more from @WeKnowSweat: bit.ly/3WoZqSm
11
Today is #WorldPsoriasisDay!
Medications for chronic skin conditions like #psoriasis have been selected for Medicare drug price negotiations. Access to treatment options must remain a priority for patients.
Learn more in DCAN's advocacy toolkit: bit.ly/4u6CiUX
8
Skin cancer is the most common type of cancer. It strikes one in five Americans and accounts for one-third of all U.S. cancer diagnoses. But, skin cancer is “cancer that patients can see,” and when detected early, it’s highly treatable.
Read more: healthpolicytoday.org/2023/0…
8
#DYK? Many patients covered by Medicaid and TRICARE cannot access their medications because #vitiligo is misclassified as a cosmetic condition.
Learn more about inconsistent classification in vitiligo:
bit.ly/4crUMH1
177
October is #EczemaAwarenessMonth!
#DYK? More than 30 million Americans live with atopic dermatitis or another form of eczema. It can affect sleep, work and mental health.
Treatment options only matter when patients can access them.
Learn more: bit.ly/4i6lQAa
15
#Vitiligo and #AlopeciaAreata are systemic, immune-mediated conditions, not cosmetic concerns.
Yet when misclassified, patients on Medicare, Medicaid and TRICARE too often see medically necessary treatment delayed or denied.
Learn more: bit.ly/4hCNSDp
55
#ICYMI: DCAN hosted a webinar discussing the burden of #AlopeciaAreata from the clinician perspective, followed by an analysis of the current Medicare & Medicaid coverage landscape for those living with the condition.
Watch to learn more this #AAM: bit.ly/4saxD2m
143
When health plans misclassify #AlopeciaAreata as cosmetic, there are direct and harmful consequences, such as:
🔵 Denied coverage for evidence-based therapies
🔵 Delayed treatment
🔵 Increased emotional & psychological distress
Read more this #AAM: bit.ly/4hCNSDp
123
#AlopeciaAreata is often misunderstood as a cosmetic condition despite its autoimmune pathology and chronic nature.
Read more in DCAN's policy brief this #AlopeciaAwarenessMonth: bit.ly/3PGlqFd
17
Today is #WorldLymphomaAwarenessDay!
Cutaneous lymphomas are rare skin cancers often mistaken for eczema or psoriasis, leading to delayed diagnosis. Most are chronic and treatable. Knowledge is power.
Learn more from @skinlymphoma: bit.ly/3Si0bVV
1
6
It's #EczemaAwarenessWeek!
Mark your calendars! @nationaleczema is hosting a webinar on October 1, highlighting eczema's impact across the nation, spanning all ages and insurance types.
Learn more & register: bit.ly/4qQ9yig
15
Listen to the Marcos family as they discuss the barriers many families face and why patient advocacy is essential to improving awareness and access for those living with #AlopeciaAreata.
Watch to learn more during #AlopeciaAwarenessMonth: bit.ly/4hhqv29
8
September is #AlopeciaAwarenessMonth!
#DYK? Insurance coverage of treatments for #AlopeciaAreata is highly variable and restricted.
Learn more: bit.ly/44qaDm9
9
Training to become a doctor is notoriously grueling. Yet despite the thousands of hours of education, there’s one topic that’s not often taught: how to navigate insurer’s utilization management tactics.
Read more: healthpolicytoday.org/2024/1…
5
Hear from the Marcos family as they open up about the barriers many people with alopecia areata face, and why patient advocacy matters for improving awareness and access.
Watch to learn more: bit.ly/3U2KYy3
25
Barriers to patient access in dermatological care include:
🔹Misclassification of skin diseases as “cosmetic”
🔹Copay accumulators
🔹Step therapy
Read more in DCAN & @USskincoalition's briefing report: bit.ly/4vWBBgU
Denied Medicare Part D coverage for an FDA-approved JAK inhibitor for #AlopeciaAreata?
@NAAF_Org wants to hear your story to help advocate for better access to care. Share here: naaf.org/has-medicare-part-d…
14
#DYK? #Vitiligo and #AlopeciaAreata are dermatological health conditions that have medical consequences that extend far beyond changes to physical appearance.
Read more: bit.ly/4hCNSDp
55
#StepTherapy aims to cut expenses for insurance companies, but the cost to patients with skin conditions is just too high.
Watch to learn more: bit.ly/4c9LCOM
10